EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

New perspectives in the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B



New perspectives in the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B



Hepatology 41(6): 1402-1406




(PDF emailed within 0-6 h: $19.90)

Accession: 049689616

Download citation: RISBibTeXText

PMID: 15915467

DOI: 10.1002/hep.20743



Related references

Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies. Hepatology Research 46(10): 992-1001, 2015

Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom. Value in Health 18(6): 800-809, 2016

An analysis of clinical features in HBeAg-negative and HBeAg-positive chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 15(6): 428-430, 2007

Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B. Journal of Viral Hepatitis 19(2): E41-E47, 2012

Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients. Jundishapur Journal of Microbiology 8(3): E21444-E21444, 2015

Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B. Liver International 30(8): 1115-1122, 2010

Reversion from HBeAg negative to HBeAg positive phenotype after interferon therapy for chronic hepatitis B. Hepatology 30(4 PART 2): 601A, 1999

Histological Spectrum of Chronic Hepatitis in HBeAg Positive and HBeAg Negative Hepatitis B Virus Infection. Mymensingh Medical Journal 24(4): 679-683, 2016

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. Plos One 8(3): E58236-E58236, 2013

What Should Be the Endpoints of Oral Therapy in HBeAg-positive Versus HBeAg-negative Patients with Chronic Hepatitis B. Current Hepatitis Reports 11(2): 65-69, 2012

Effectiveness of Peginterferon Alfa-2a Therapy in HBeAg-Positive and HBeAg-Negative Patients with Chronic Hepatitis B: Final Results 3 Years Post-Treatment of the Prospective, Global, Observational S-Collate Study. Journal of Hepatology 64(2): S598-S599, 2016

Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT. Zhonghua Gan Zang Bing Za Zhi 20(5): 348-352, 2012

A comparison of clinical and virological characteristics of 1686 cases of HBeAg-negative and HBeAg-positive chronic hepatitis B. Zhonghua Nei Ke Za Zhi 44(9): 648-651, 2005

Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B. Hepatology International 2(1): 102-110, 2008

The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis. Zhonghua Yi Xue Za Zhi 87(26): 1832-1835, 2007